FirstWave Capital Management LLC Sells 16,337 Shares of Astera Labs, Inc. $ALAB

FirstWave Capital Management LLC decreased its stake in shares of Astera Labs, Inc. (NASDAQ:ALAB) by 59.9% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,953 shares of the company’s stock after selling 16,337 shares during the quarter. Astera Labs comprises about 2.3% of FirstWave Capital Management LLC’s portfolio, making the stock its 13th largest holding. FirstWave Capital Management LLC’s holdings in Astera Labs were worth $5,291,000 as of its most recent filing with the SEC.

Other institutional investors also recently bought and sold shares of the company. Reflection Asset Management purchased a new stake in Astera Labs in the 4th quarter worth $25,000. Keating Financial Advisory Services Inc. bought a new stake in shares of Astera Labs in the second quarter worth about $25,000. Archer Investment Corp purchased a new stake in shares of Astera Labs in the second quarter worth about $30,000. Smartleaf Asset Management LLC boosted its stake in Astera Labs by 422.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 188 shares of the company’s stock valued at $32,000 after buying an additional 152 shares during the last quarter. Finally, Towarzystwo Funduszy Inwestycyjnych PZU SA bought a new position in Astera Labs during the fourth quarter valued at approximately $33,000. 60.47% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have issued reports on ALAB. TD Cowen reduced their price objective on Astera Labs from $425.00 to $375.00 and set a “hold” rating on the stock in a research note on Wednesday, August 5th. Zacks Research upgraded Astera Labs from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, August 11th. Morgan Stanley raised their target price on shares of Astera Labs to $335.00 and gave the company an “overweight” rating in a report on Monday, August 3rd. Bank of America boosted their price target on shares of Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research report on Tuesday, June 23rd. Finally, Jefferies Financial Group upped their price target on shares of Astera Labs from $270.00 to $450.00 and gave the company a “buy” rating in a research note on Wednesday, August 5th. One investment analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and eight have issued a Hold rating to the stock. According to MarketBeat, Astera Labs presently has an average rating of “Moderate Buy” and a consensus price target of $348.33.

Key Astera Labs News

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Demand for Astera Labs’ Scorpio, Aries and Taurus connectivity platforms is supporting expectations for strong third-quarter growth and strengthening the company’s position in AI data-center infrastructure. ALAB Stock Down 24% in a Month: Should Investors Buy the Dip or Wait?
• Positive Sentiment: The company’s latest quarterly results exceeded expectations, with earnings per share of $0.80 versus the $0.69 consensus estimate and revenue of $392.4 million versus $360.85 million. Revenue rose 104.5% year over year, while management issued third-quarter EPS guidance of $1.16 to $1.21.
• Positive Sentiment: Analyst sentiment remains generally constructive: Astera Labs has a “Moderate Buy” consensus rating and an average price target of $348.33, above recent trading levels. Northland upgraded the shares to outperform with a $350 target, while Morgan Stanley maintained an overweight rating with a $335 target.
• Neutral Sentiment: Despite the favorable growth outlook, ALAB has declined 13.9% since its latest earnings report and 24% over the past month, reflecting elevated valuation expectations and uncertainty about the pace of future growth. The stock’s high beta and elevated earnings multiple may contribute to volatility. Why Is Astera Labs Down Since Its Earnings Report?
• Negative Sentiment: Director Manuel Alba sold 183,000 shares for approximately $51.3 million, reducing his holdings by 41.9%. Director Stefan Dyckerhoff separately sold 12,499 shares worth about $3.4 million. The transactions were made under pre-arranged Rule 10b5-1 plans, which reduces their value as a discretionary bearish signal, but the sales may still weigh on investor sentiment and add near-term supply. SEC Insider Trading Filing

Insider Activity at Astera Labs

In other Astera Labs news, Director Stefan Dyckerhoff sold 8,994 shares of Astera Labs stock in a transaction on Thursday, August 6th. The shares were sold at an average price of $311.83, for a total transaction of $2,804,599.02. Following the completion of the transaction, the director directly owned 3,970 shares of the company’s stock, valued at $1,237,965.10. The trade was a 69.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total transaction of $30,845,920.50. Following the completion of the sale, the chief executive officer owned 1,266,665 shares of the company’s stock, valued at $431,109,432.75. This trade represents a 6.68% decrease in their position. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 592,244 shares of company stock valued at $209,729,973 over the last three months. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of ALAB stock opened at $310.40 on Friday. The company has a market cap of $53.85 billion, a PE ratio of 153.66 and a beta of 3.77. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48. The stock’s 50 day simple moving average is $330.74 and its two-hundred day simple moving average is $254.36.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. The firm had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The company’s quarterly revenue was up 104.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.44 EPS. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts expect that Astera Labs, Inc. will post 2.7 EPS for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.